224 related articles for article (PubMed ID: 34251554)
1. Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
Lizarraga IM; Schroeder MC; Jatoi I; Sugg SL; Trentham-Dietz A; Hoeth L; Chrischilles EA
Ann Surg Oncol; 2021 Dec; 28(13):8752-8765. PubMed ID: 34251554
[TBL] [Abstract][Full Text] [Related]
2. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract][Full Text] [Related]
3. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
[TBL] [Abstract][Full Text] [Related]
4. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
[TBL] [Abstract][Full Text] [Related]
5. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
Huang J; Chagpar A
J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
[TBL] [Abstract][Full Text] [Related]
6. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
7. 'Taking control of cancer': understanding women's choice for mastectomy.
Covelli AM; Baxter NN; Fitch MI; McCready DR; Wright FC
Ann Surg Oncol; 2015 Feb; 22(2):383-91. PubMed ID: 25190120
[TBL] [Abstract][Full Text] [Related]
8. Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
ElSherif A; Armanyous S; Gentle CK; Al-Hilli Z; Valente SA
Am J Surg; 2022 Mar; 223(3):533-537. PubMed ID: 34924172
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
[TBL] [Abstract][Full Text] [Related]
10. The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.
Hawley ST; Griffith KA; Hamilton AS; Ward KC; Morrow M; Janz NK; Katz SJ; Jagsi R
Cancer; 2017 Dec; 123(23):4547-4555. PubMed ID: 28810062
[TBL] [Abstract][Full Text] [Related]
11. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
Tollow P; Williams VS; Harcourt D; Paraskeva N
Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
[TBL] [Abstract][Full Text] [Related]
12. An Evaluation of the Choice for Contralateral Prophylactic Mastectomy and Patient Concerns About Recurrence in a Reconstructed Cohort.
Sando IC; Billig JI; Ambani SW; Kraft CT; Kidwell KM; Zhong L; Chung KC; Momoh AO
Ann Plast Surg; 2018 Apr; 80(4):333-338. PubMed ID: 29166308
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
Huang J; Chagpar A
Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
[TBL] [Abstract][Full Text] [Related]
14. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Receptor Status on Mastectomy and Contralateral Prophylactic Mastectomy Rates in Early Stage Invasive Breast Carcinoma.
Dutta SW; Trifiletti DM; Grover S; Romano KD; Janowski EM; Showalter SL
Clin Breast Cancer; 2018 Apr; 18(2):121-127. PubMed ID: 28811185
[TBL] [Abstract][Full Text] [Related]
16. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
[TBL] [Abstract][Full Text] [Related]
17. Contralateral prophylactic mastectomy for unilateral breast cancer in Chinese female population: a retrospective cohort study.
Zhu J; Min N; Zhang Y; Wu H; Hong C; Geng R; Wei Y; Guan Q; Zheng Y; Li X
Gland Surg; 2023 Dec; 12(12):1668-1685. PubMed ID: 38229836
[TBL] [Abstract][Full Text] [Related]
18. An Analysis of the Decisions Made for Contralateral Prophylactic Mastectomy and Breast Reconstruction.
Buchanan PJ; Abdulghani M; Waljee JF; Kozlow JH; Sabel MS; Newman LA; Chung KC; Momoh AO
Plast Reconstr Surg; 2016 Jul; 138(1):29-40. PubMed ID: 27348637
[TBL] [Abstract][Full Text] [Related]
19. Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.
D'Agostino TA; Brewster AM; Peterson SK; Bedrosian I; Parker PA
Transl Behav Med; 2020 May; 10(2):347-354. PubMed ID: 30561744
[TBL] [Abstract][Full Text] [Related]
20. Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer.
Chen H; Zhang P; Zhang M; Wang M; Bai F; Wu K
J Surg Res; 2019 Jul; 239():224-232. PubMed ID: 30856515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
